STOP THE WAR! Let’s support Ukraine Together

Shopping Cart

Eucrates Biomedical Acquisition Corp. (EUCRU) Prices $100M IPO

IPO-Pricing
TOP-3

DiamondPeak Holdings Corp. (DPHC) Shareholders Approve Lordstown Deal

Oct 23, 2020 INTEL by Nicholas Alan Clayton
DiamondPeak Holdings Corp. (NASDAQ:DPHC) announced that it has secured shareholder approval for its business combination with electric vehicle (EV) company Lordstown in a vote October 22. This approval and other proposals relating to closing the agreement and setting the combined entity’s board passed overwhelmingly with no measure receiving dissenting votes that eclipsed 1% of the total.
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
SPAC pricing
IPO-Pricing
deal-terms-2

Churchill Capital V (CCV.U) Upsizes & Removes New Term

Oct 22, 2020 INTEL by Kristi Marvin
The Churchill Capital Corp. team, which filed for their fifth SPAC earlier this month (CCV.U), filed an amendment tonight with some big changes.  The original term that had Churchill V placing only 90% of funds in trust, with the other 10% held in escrow and not to be contributed to trust unless at least 85%
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Legacy-onyx
carlotz-4x6

Acamar Partners Acquisition Corp. (ACAM) to Combine with CarLotz in $827Mn Deal

Oct 22, 2020 INTEL by Kristi Marvin
Acamar Partners Acquisition Corp. (ACAM), a publicly-traded special purpose acquisition company, and CarLotz, Inc., one of the largest privately-held used vehicle retail disruptors with the industry’s only consignment-to-retail sales platform, announced today they executed a definitive business combination agreement that would make CarLotz a public company. At closing, anticipated in the fourth quarter of 2020,
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Alert-2

Tenzing Acquisition Corp. (TZAC) Adds a Backstop

Oct 22, 2020 INTEL by Nicholas Alan Clayton
Tenzing Acquisition Corp. (NASDAQ:TZAC) announced in an 8-K filing this morning that it has entered into a backstop agreement ahead of its shareholder vote to approve its combination with Reviva Pharmaceutics. According to the agreement, Reviva and other investors to purchase a total 417,518 shares through either private or open-market transactions by October 23. For
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
4dpharma

Longevity Acquisition Corporation (LOAC) to Combine with 4D pharma PLC

Oct 22, 2020 INTEL by Nicholas Alan Clayton
Longevity Acquisition Corporation (NASDAQ:LOAC) announced this morning it has signed a definitive merger agreement with 4D pharma PLC (AIM:DDDD) that would list the company in the US. 4D is developing medications that use human gut bacteria to potentially treat a range of diseases including certain types of cancer, neurodegenerative conditions and autoimmune diseases. The deal
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
Pivotal-xl-fleet-4x6
Teaser

Alberton Acquisition Corp. (ALAC) Drops a Teaser

Oct 22, 2020 INTEL by Kristi Marvin
Alberton Acquisition Corp. (ALAC), put out an 8-K this morning announcing some changes to it’s board, but also included a teaser ahead of it’s forthcoming extension vote on Monday, October 26th. Notably, Mr. John W. Allen resigned from his positions as an independent director and the chairman of the compensation committee and Mr. Harry Edelson
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
ipo
YAC_Logo2
nuvation-bio

Panacea Acquisition Corp. (PANA) to Combine with Nuvation Bio in $1.3Bn Deal

Oct 21, 2020 INTEL by Nicholas Alan Clayton
Biotech firm Nuvation Bio announced this morning that it had entered into a definitive business combination agreement with Panacea Acquisition Corp. (NYSE:PANA) for an enterprise value of about $1.3 billion. New York-based Nuvation Bio is developing six novel treatments for a variety of cancer types. The combined company is to be remain listed on the
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
Supernova-logo